semaglutide approved for cardiovascular Updates in Medicine | Not just weight loss anymore — is now part of risk reduction. 🫀 Semaglutide tops dulaglutide when treating

Neither Wegovy nor Ozempic, which also contains semaglutide but is licensed to help people with diabetes manage their blood sugar (it is frequently used off-label for weight loss), are approved for sale in India and Novos India Managing Director Vikrant Shrotriya told Reuters the company is planning to officially launch Wegovy in the country in 2026, admitting that it is difficult to trace illegal sellers in India

New Drug Approval

10 Conclusions and future directions While the existence of physical stimuli within the breast tumor microenvironment and throughout the metastatic cascade has been acknowledged for several decades, our understanding of their role in breast cancer remains incomplete

An injection bypasses all of that